A detailed history of Renaissance Investment Group LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Renaissance Investment Group LLC holds 1,040 shares of LLY stock, worth $827,496. This represents 0.2% of its overall portfolio holdings.

Number of Shares
1,040
Previous 1,040 -0.0%
Holding current value
$827,496
Previous $941,000 2.13%
% of portfolio
0.2%
Previous 0.21%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024

SELL
$592.2 - $792.28 $118,440 - $158,456
-200 Reduced 16.13%
1,040 $809,000
Q2 2023

Jul 06, 2023

BUY
$350.74 - $468.98 $14,029 - $18,759
40 Added 3.33%
1,240 $581,000
Q4 2022

Jan 11, 2023

SELL
$321.55 - $374.67 $128,620 - $149,868
-400 Reduced 25.0%
1,200 $0
Q3 2022

Oct 25, 2022

BUY
$296.48 - $337.87 $474,368 - $540,592
1,600 New
1,600 $557,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Renaissance Investment Group LLC Portfolio

Follow Renaissance Investment Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Investment Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Investment Group LLC with notifications on news.